Overview
- 12 inspections across 12 sites are on record.
- 41 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-01-29.
At a glance
Inspections
12
Sites
12
Observations
41
Career since
Jan 2024
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Cambridge Isotope Laboratories, Inc. | 29 Jan 2026 | Human Drugs | |
| Biocon Generics Inc. | 10 Oct 2025 | Human Drugs | On file |
| Colgate-Palmolive Company | 20 Aug 2025 | Human Drugs | |
| Ecolab, Inc. | 5 Jun 2025 | Human Drugs | On file |
| Osmotica Pharmaceutical US LLC | 2 May 2025 | Human Drugs | On file |
Sites inspected
Cambridge Isotope Laboratories, Inc.Andover, United States1 insp.
Biocon Generics Inc.Cranbury, United States1 insp.
Colgate-Palmolive CompanyPiscataway, United States1 insp.
Ecolab, Inc.Huntington, United States1 insp.
Osmotica Pharmaceutical US LLCMarietta, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Veronica Fuentes2 shared
Annet R Rajan2 shared
Jonathan G Matrisciano1 shared
Scott D Mcgrew1 shared
Tomika L Crafter1 shared
Rodney L Tinzie1 shared
Samantha E Cleek1 shared
Paranthaman SenthamaraiKannan1 shared
Saundrea A Munroe1 shared
Young K Chou1 shared
Full investigator report
Get the verbatim findings behind Andrew O Ejiofor's 41 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site